Downloadable Flyer: Accelerate Your Nasal Spray ANDA Submission with Our IVBE Device Equivalence Package
Cormica’s IVBE Device Equivalence Package for nasal sprays is designed to meet FDA requirements efficiently through validated methodologies and lifecycle-based testing.
Our flyer outlines the complete package including:
- Full scope of IVBE tests for nasal sprays
- Recommended validated methods
- Sample and batch requirements
- Lifecycle testing stages
Download the flyer to see how our tailored in vitro bioequivalence (IVBE) testing solutions can accelerate your nasal spray’s path to FDA submission and approval.
Cormica’s global team of regulatory experts and GMP-accredited labs provide end-to-end ANDA support, from method development to stability and bioequivalence testing. We help you reduce complexity and accelerate time to market with proven strategies tailored to FDA expectations.
Explore Our Full ANDA Support Services for Generic Pharmaceutical Development

Type:
Published:
Download:
We will email you the link to the PDF file.